跳至主要内容
临床试验/NCT01914445
NCT01914445Unknown不适用

Chromoendoscopy of the Colon After Oral Administration of Indigo Carmine

Hillel Yaffe Medical Center1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2013年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
10
试验地点
1
主要终点
Efficacy of Indigo Carmine during oral administration

研究概览

简要总结

The purpose of this study is to examine whether oral administration of Indigo Carmine together with Polyethylene Glycol (PEG), the usual colon preparatory solution, can be used instead of staining during the examination itself.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients suffering from Inflammatory Bowel Disease
  • Patients under surveillance for Disease-Associated Lesions and Masses (DALM)

排除标准

  • All others

研究组 & 干预措施

Indigo Carmine

Experimental

Indigo Carmine (2 mg per kilo) and 2nd half of PEG dose will be orally administered to patients prior to colonoscopy.

干预措施: Indigo Carmine (Drug)

结局指标

主要结局

Efficacy of Indigo Carmine during oral administration

时间窗: One hour

The efficacy of Indigo Carmine in staining tissues to better characterize, delineate, and highlight the gastrointestinal mucosa will be determined during the colonoscopic examination. Biopsies will be taken from suspicious lesions.

次要结局

未报告次要终点

研究者

申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验